Tennessee Senate Bill SB1067

Tennessee 2023-2024 Regular Session

• Introduced: 1/31/23

Caption

AN ACT to amend Tennessee Code Annotated, Title 4; Title 8; Title 47, Chapter 18; Title 53 and Title 68, relative to medical products.

Impact

The introduction of SB1067 is significant as it seeks to enhance transparency and accountability in the dealings between state agencies and medical product manufacturers. This move responds to growing concerns about the influence of private industry on public health policy. By necessitating disclosures, SB1067 intends to ensure that government policies regarding medical products are developed with the best interests of public welfare in mind, free from undue industry influence.

Summary

Senate Bill 1067 aims to amend various sections of the Tennessee Code Annotated concerning the regulation of medical products. This legislation proposes additions that address the interactions between government agencies and manufacturers of medical products. Specifically, it requires that any government agency that holds membership in an organization associated with these manufacturers disclose its relationship and any potential conflicts of interest when developing or implementing state policy related to medical products.

Contention

While the intent behind SB1067 is to fortify public trust in health regulations, some stakeholders might perceive potential challenges. Critics may argue that the legislation could complicate relationships between state agencies and legitimate medical product manufacturers, possibly leading to hesitance in meaningful partnerships. Furthermore, there is an underlying debate regarding the balance between necessary oversight and the risks of bureaucratization, which could hinder innovation and responsiveness in healthcare solutions.